- Home
- ENVB
as 07-26-2024 4:00pm EST
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders. The company's lead program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. Enveric is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, being studied as a treatment of psychiatric disorders.
| Founded: | 1994 | Country: | United States |
| Employees: | N/A | City: | NAPLES |
| Market Cap: | 5.9M | IPO Year: | N/A |
| Target Price: | $10.00 | AVG Volume (30 days): | 413.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -6.42 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.41 - $3.90 | Next Earning Date: | 08-09-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Enveric Biosciences Inc. News
ENVB Breaking Stock News: Dive into ENVB Ticker-Specific Updates for Smart Investing
Business Wire
2 days ago
Enveric Biosciences Announces Preclinical Results Confirming Potential of EB-003 to be Dosed Orally
Business Wire
11 days ago
Aries Science & Technology and Enveric Biosciences Announce Licensing Agreement
Business Wire
17 days ago
Enveric Biosciences Announces Patent Granted for Drug Candidate
Simply Wall St.
25 days ago
Is Enveric Biosciences, Inc. (NASDAQ:ENVB) Trading At A 36% Discount?
GlobeNewswire
a month ago
Diamond Equity Research Releases Update Note on Enveric Biosciences Inc. (NASDAQ: ENVB)
Business Wire
a month ago
Enveric Biosciences Provides Strategic Outlook and Pipeline Update, Elevating EB-003 to Lead Development Candidate
Journal-News, Hamilton, Ohio
2 months ago
Retiring ODW executive to be first inductee in Hamilton Business Hall of Fame
TechCrunch
2 months ago
Cat-sitting startup Meowtel clawed its way to profitability despite trouble raising from dog-focused VCs
Compare ENVB vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ENVB Enveric Biosciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.